BackWelgene Biotech ,Ltd. Overview

Welgene Biotech ,Ltd. Other Current Liabilities

Latest other current liabilities for 6661.TWO: $27M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$26.88M
↓ 68.82% YoYΔ $-59.34M vs prior year quarter

Peer trimmed avg / median

Loading

Welgene Biotech ,Ltd. Other Current Liabilities History

Loading

Welgene Biotech ,Ltd. vs. peers: Other Current Liabilities Comparison

Loading

Welgene Biotech ,Ltd. Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Welgene Biotech ,Ltd. (6661.TWO) FAQ

Welgene Biotech ,Ltd. posts a other current liabilities of $27M as of June 2026. That compares with $86M in the prior-year period — down 68.8% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Welgene Biotech ,Ltd.'s other current liabilities was $86M. The latest reading is $27M — a 68.8% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of Welgene Biotech ,Ltd.'s financial statement story. At $27M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 6661.TWO's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Welgene Biotech ,Ltd.'s other metric pages and overview cover the third.